Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System

Neuron

Volumn 92, Issue 4, 2016, Pages 780-795

  Martinez, Fernando J ^a,b   Pratt, Gabriel A ^a,b   Van Nostrand, Eric L ^a,b   Batra, Ranjan ^a,b   Huelga, Stephanie C ^a,b   Kapeli, Katannya ^a,b,c   Freese, Peter ^d   Chun, Seung J ^e   Ling, Karen ^e   Gelboin Burkhart, Chelsea ^a,b   Fijany, Layla ^a,b   Wang, Harrison C ^a,b   Nussbacher, Julia K ^a,b   Broski, Sara M ^f   Kim, Hong Joo ^g   Lardelli, Rea ^h   Sundararaman, Balaji ^a,b   Donohue, John P ⁱ   Javaherian, Ashkan ^f   Lykke Andersen, Jens ^h   Finkbeiner, Steven ^f,j   Bennett, C Frank ^e   Ares, Manuel ⁱ   Burge, Christopher B ^d   Taylor, J Paul ^g   Rigo, Frank ^e   Yeo, Gene W ^a,b,c,k   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e ISIS PHARMACEUTICALS   (United States)

^f GLADSTONE INSTITUTE OF NEUROLOGICAL DISEASE   (United States)

^g ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^h UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k AGENCY FOR SCIENCE   (Singapore)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO AMINO ACID OXIDASE; HNRNPA2 PROTEIN; HNRNPB1 PROTEIN; MICRORNA; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN GROUP A B;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL GRANULE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; EXON SKIPPING; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; INDUCED PLURIPOTENT STEM CELL; MOTONEURON; MOUSE; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN RNA BINDING; SPLICEOSOME; ANIMAL; CASE CONTROL STUDY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MUTATION; PROTEIN TRANSPORT;

ALTERNATIVE SPLICING; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CASE-CONTROL STUDIES; CELL SURVIVAL; D-AMINO-ACID OXIDASE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MOTOR NEURONS; MUTATION; POLYADENYLATION; PROTEIN TRANSPORT;

EID: 84997208317     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2016.09.050     Document Type: Article

References (65)

1. Ainger, K., Avossa, D., Diana, A.S., Barry, C., Barbarese, E., Carson, J.H., Transport and localization elements in myelin basic protein mRNA. J. Cell Biol. 138 (1997), 1077–1087.
2. Alarcón, C.R., Goodarzi, H., Lee, H., Liu, X., Tavazoie, S., Tavazoie, S.F., HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell 162 (2015), 1299–1308.
3. Belzil, V.V., Gendron, T.F., Petrucelli, L., RNA-mediated toxicity in neurodegenerative disease. Mol. Cell. Neurosci. 56 (2013), 406–419.
4. Berson, A., Barbash, S., Shaltiel, G., Goll, Y., Hanin, G., Greenberg, D.S., Ketzef, M., Becker, A.J., Friedman, A., Soreq, H., Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice. EMBO Mol. Med. 4 (2012), 730–742.
5. Burkhardt, M.F., Martinez, F.J., Wright, S., Ramos, C., Volfson, D., Mason, M., Garnes, J., Dang, V., Lievers, J., Shoukat-Mumtaz, U., et al. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol. Cell. Neurosci. 56 (2013), 355–364.
6. Burnet, P.W., Eastwood, S.L., Bristow, G.C., Godlewska, B.R., Sikka, P., Walker, M., Harrison, P.J., D-amino acid oxidase activity and expression are increased in schizophrenia. Mol. Psychiatry 13 (2008), 658–660.
7. Chambers, S.M., Fasano, C.A., Papapetrou, E.P., Tomishima, M., Sadelain, M., Studer, L., Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27 (2009), 275–280.
8. Cirulli, E.T., Lasseigne, B.N., Petrovski, S., Sapp, P.C., Dion, P.A., Leblond, C.S., Couthouis, J., Lu, Y.F., Wang, Q., Krueger, B.J., et al., FALS Sequencing Consortium. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347 (2015), 1436–1441.
9. Clower, C.V., Chatterjee, D., Wang, Z., Cantley, L.C., Vander Heiden, M.G., Krainer, A.R., The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc. Natl. Acad. Sci. USA 107 (2010), 1894–1899.
10. Couthouis, J., Hart, M.P., Shorter, J., DeJesus-Hernandez, M., Erion, R., Oristano, R., Liu, A.X., Ramos, D., Jethava, N., Hosangadi, D., et al. A yeast functional screen predicts new candidate ALS disease genes. Proc. Natl. Acad. Sci. USA 108 (2011), 20881–20890.
11. Du, Z.W., Chen, H., Liu, H., Lu, J., Qian, K., Huang, C.L., Zhong, X., Fan, F., Zhang, S.C., Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat. Commun., 6, 2015, 6626.
12. Fähling, M., Mrowka, R., Steege, A., Martinka, P., Persson, P.B., Thiele, B.J., Heterogeneous nuclear ribonucleoprotein-A2/B1 modulate collagen prolyl 4-hydroxylase, alpha (I) mRNA stability. J. Biol. Chem. 281 (2006), 9279–9286.
13. Horiike, K., Tojo, H., Arai, R., Nozaki, M., Maeda, T., D-amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes. Brain Res. 652 (1994), 297–303.
14. Huelga, S.C., Vu, A.Q., Arnold, J.D., Liang, T.Y., Liu, P.P., Yan, B.Y., Donohue, J.P., Shiue, L., Hoon, S., Brenner, S., et al. Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep. 1 (2012), 167–178.
15. Huppertz, I., Attig, J., D'Ambrogio, A., Easton, L.E., Sibley, C.R., Sugimoto, Y., Tajnik, M., König, J., Ule, J., iCLIP: protein-RNA interactions at nucleotide resolution. Methods 65 (2014), 274–287.
16. Hutchison, S., LeBel, C., Blanchette, M., Chabot, B., Distinct sets of adjacent heterogeneous nuclear ribonucleoprotein (hnRNP) A1/A2 binding sites control 5′ splice site selection in the hnRNP A1 mRNA precursor. J. Biol. Chem. 277 (2002), 29745–29752.
17. Iguchi, Y., Katsuno, M., Niwa, J., Takagi, S., Ishigaki, S., Ikenaka, K., Kawai, K., Watanabe, H., Yamanaka, K., Takahashi, R., et al. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain 136 (2013), 1371–1382.
18. Johnson, J.O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V.M., Trojanowski, J.Q., Gibbs, J.R., Brunetti, M., Gronka, S., Wuu, J., et al., ITALSGEN Consortium. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68 (2010), 857–864.
19. Kabashi, E., Valdmanis, P.N., Dion, P., Spiegelman, D., McConkey, B.J., Vande Velde, C., Bouchard, J.P., Lacomblez, L., Pochigaeva, K., Salachas, F., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40 (2008), 572–574.
20. Kapeli, K., Pratt, G.A., Vu, A.Q., Hutt, K.R., Martinez, F.J., Sundararaman, B., Batra, R., Freese, P., Lambert, N.J., Huelga, S.C., et al. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat. Commun., 7, 2016, 12143.
21. Kawazoe, T., Tsuge, H., Pilone, M.S., Fukui, K., Crystal structure of human D-amino acid oxidase: context-dependent variability of the backbone conformation of the VAAGL hydrophobic stretch located at the si-face of the flavin ring. Protein Sci. 15 (2006), 2708–2717.
22. Kedersha, N., Cho, M.R., Li, W., Yacono, P.W., Chen, S., Gilks, N., Golan, D.E., Anderson, P., Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J. Cell Biol. 151 (2000), 1257–1268.
23. Kim, H.J., Kim, N.C., Wang, Y.D., Scarborough, E.A., Moore, J., Diaz, Z., MacLea, K.S., Freibaum, B., Li, S., Molliex, A., et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495 (2013), 467–473.
24. Kosturko, L.D., Maggipinto, M.J., Korza, G., Lee, J.W., Carson, J.H., Barbarese, E., Heterogeneous nuclear ribonucleoprotein (hnRNP) E1 binds to hnRNP A2 and inhibits translation of A2 response element mRNAs. Mol. Biol. Cell 17 (2006), 3521–3533.
25. Kosuge, Y., Sekikawa-Nishida, K., Negi, H., Ishige, K., Ito, Y., Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice. Neurosci. Lett. 454 (2009), 165–169.
26. Lagier-Tourenne, C., Polymenidou, M., Cleveland, D.W., TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 19:R1 (2010), R46–R64.
27. Lagier-Tourenne, C., Polymenidou, M., Hutt, K.R., Vu, A.Q., Baughn, M., Huelga, S.C., Clutario, K.M., Ling, S.C., Liang, T.Y., Mazur, C., et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 15 (2012), 1488–1497.
28. Lalmansingh, A.S., Urekar, C.J., Reddi, P.P., TDP-43 is a transcriptional repressor: the testis-specific mouse acrv1 gene is a TDP-43 target in vivo. J. Biol. Chem. 286 (2011), 10970–10982.
29. Lambert, N., Robertson, A., Jangi, M., McGeary, S., Sharp, P.A., Burge, C.B., RNA Bind-n-Seq: quantitative assessment of the sequence and structural binding specificity of RNA binding proteins. Mol. Cell 54 (2014), 887–900.
30. Liu-Yesucevitz, L., Bilgutay, A., Zhang, Y.J., Vanderweyde, T., Citro, A., Mehta, T., Zaarur, N., McKee, A., Bowser, R., Sherman, M., et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS ONE, 5, 2010, e13250.
31. Lovci, M.T., Ghanem, D., Marr, H., Arnold, J., Gee, S., Parra, M., Liang, T.Y., Stark, T.J., Gehman, L.T., Hoon, S., et al. Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridges. Nat. Struct. Mol. Biol. 20 (2013), 1434–1442.
32. Mackenzie, I.R., Bigio, E.H., Ince, P.G., Geser, F., Neumann, M., Cairns, N.J., Kwong, L.K., Forman, M.S., Ravits, J., Stewart, H., et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61 (2007), 427–434.
33. McGlincy, N.J., Tan, L.Y., Paul, N., Zavolan, M., Lilley, K.S., Smith, C.W., Expression proteomics of UPF1 knockdown in HeLa cells reveals autoregulation of hnRNP A2/B1 mediated by alternative splicing resulting in nonsense-mediated mRNA decay. BMC Genomics, 11, 2010, 565.
34. Mitchell, J., Paul, P., Chen, H.J., Morris, A., Payling, M., Falchi, M., Habgood, J., Panoutsou, S., Winkler, S., Tisato, V., et al. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proc. Natl. Acad. Sci. USA 107 (2010), 7556–7561.
35. Mohagheghi, F., Prudencio, M., Stuani, C., Cook, C., Jansen-West, K., Dickson, D.W., Petrucelli, L., Buratti, E., TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor. Hum. Mol. Genet. 25 (2016), 534–545.
36. Molliex, A., Temirov, J., Lee, J., Coughlin, M., Kanagaraj, A.P., Kim, H.J., Mittag, T., Taylor, J.P., Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163 (2015), 123–133.
37. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006), 130–133.
38. Nussbacher, J.K., Batra, R., Lagier-Tourenne, C., Yeo, G.W., RNA-binding proteins in neurodegeneration: Seq and you shall receive. Trends Neurosci. 38 (2015), 226–236.
39. Pasinelli, P., Brown, R.H., Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7 (2006), 710–723.
40. Paul, P., de Belleroche, J., The role of D-serine and glycine as co-agonists of NMDA receptors in motor neuron degeneration and amyotrophic lateral sclerosis (ALS). Front. Synaptic Neurosci., 6, 2014, 10.
41. Paul, P., Murphy, T., Oseni, Z., Sivalokanathan, S., de Belleroche, J.S., Pathogenic effects of amyotrophic lateral sclerosis-linked mutation in D-amino acid oxidase are mediated by D-serine. Neurobiol. Aging 35 (2014), 876–885.
42. Polymenidou, M., Lagier-Tourenne, C., Hutt, K.R., Huelga, S.C., Moran, J., Liang, T.Y., Ling, S.C., Sun, E., Wancewicz, E., Mazur, C., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14 (2011), 459–468.
43. Polymenidou, M., Lagier-Tourenne, C., Hutt, K.R., Bennett, C.F., Cleveland, D.W., Yeo, G.W., Misregulated RNA processing in amyotrophic lateral sclerosis. Brain Res. 1462 (2012), 3–15.
44. Sasabe, J., Chiba, T., Yamada, M., Okamoto, K., Nishimoto, I., Matsuoka, M., Aiso, S., D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis. EMBO J. 26 (2007), 4149–4159.
45. Sasabe, J., Miyoshi, Y., Suzuki, M., Mita, M., Konno, R., Matsuoka, M., Hamase, K., Aiso, S., D-amino acid oxidase controls motoneuron degeneration through D-serine. Proc. Natl. Acad. Sci. USA 109 (2012), 627–632.
46. Scekic-Zahirovic, J., Sendscheid, O., El Oussini, H., Jambeau, M., Sun, Y., Mersmann, S., Wagner, M., Dieterlé, S., Sinniger, J., Dirrig-Grosch, S., et al. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 35 (2016), 1077–1097.
47. Schwartz, J.C., Ebmeier, C.C., Podell, E.R., Heimiller, J., Taatjes, D.J., Cech, T.R., FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. Genes Dev. 26 (2012), 2690–2695.
48. Shan, J., Munro, T.P., Barbarese, E., Carson, J.H., Smith, R., A molecular mechanism for mRNA trafficking in neuronal dendrites. J. Neurosci. 23 (2003), 8859–8866.
49. Siomi, M.C., Eder, P.S., Kataoka, N., Wan, L., Liu, Q., Dreyfuss, G., Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins. J. Cell Biol. 138 (1997), 1181–1192.
50. Skibinski, G., Finkbeiner, S., Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative disease. FEBS Lett. 587 (2013), 1139–1146.
51. Sofola, O.A., Jin, P., Qin, Y., Duan, R., Liu, H., de Haro, M., Nelson, D.L., Botas, J., RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron 55 (2007), 565–571.
52. Sun, S., Ling, S.C., Qiu, J., Albuquerque, C.P., Zhou, Y., Tokunaga, S., Li, H., Qiu, H., Bui, A., Yeo, G.W., et al. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat. Commun., 6, 2015, 6171.
53. Thompson, M., Marecki, J.C., Marinesco, S., Labrie, V., Roder, J.C., Barger, S.W., Crow, J.P., Paradoxical roles of serine racemase and D-serine in the G93A mSOD1 mouse model of amyotrophic lateral sclerosis. J. Neurochem. 120 (2012), 598–610.
54. Udan-Johns, M., Bengoechea, R., Bell, S., Shao, J., Diamond, M.I., True, H.L., Weihl, C.C., Baloh, R.H., Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones. Hum. Mol. Genet. 23 (2014), 157–170.
55. Van Deerlin, V.M., Leverenz, J.B., Bekris, L.M., Bird, T.D., Yuan, W., Elman, L.B., Clay, D., Wood, E.M., Chen-Plotkin, A.S., Martinez-Lage, M., et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 7 (2008), 409–416.
56. Van Nostrand, E.L., Pratt, G.A., Shishkin, A.A., Gelboin-Burkhart, C., Fang, M.Y., Sundararaman, B., Blue, S.M., Nguyen, T.B., Surka, C., Elkins, K., et al. Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP). Nat. Methods 13 (2016), 508–514.
57. Vance, C., Rogelj, B., Hortobágyi, T., De Vos, K.J., Nishimura, A.L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323 (2009), 1208–1211.
58. Watts, G.D., Wymer, J., Kovach, M.J., Mehta, S.G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M.P., Kimonis, V.E., Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36 (2004), 377–381.
59. Wu, L.S., Cheng, W.C., Shen, C.K., Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice. J. Biol. Chem. 287 (2012), 27335–27344.
60. Xia, Z., Donehower, L.A., Cooper, T.A., Neilson, J.R., Wheeler, D.A., Wagner, E.J., Li, W., Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types. Nat. Commun., 5, 2014, 5274.
61. Xiang, S., Kato, M., Wu, L.C., Lin, Y., Ding, M., Zhang, Y., Yu, Y., McKnight, S.L., The LC domain of hnRNPA2 adopts similar conformations in hydrogel polymers, liquid-like droplets, and nuclei. Cell 163 (2015), 829–839.
62. Yang, H.C., Liu, C.M., Liu, Y.L., Chen, C.W., Chang, C.C., Fann, C.S., Chiou, J.J., Yang, U.C., Chen, C.H., Faraone, S.V., et al. The DAO gene is associated with schizophrenia and interacts with other genes in the Taiwan Han Chinese population. PLoS ONE, 8, 2013, e60099.
63. Yang, C., Wang, H., Qiao, T., Yang, B., Aliaga, L., Qiu, L., Tan, W., Salameh, J., McKenna-Yasek, D.M., Smith, T., et al. Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 111 (2014), E1121–E1129.
64. Zhang, Y., Chen, K., Sloan, S.A., Bennett, M.L., Scholze, A.R., O'Keeffe, S., Phatnani, H.P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34 (2014), 11929–11947.
65. Zisoulis, D.G., Lovci, M.T., Wilbert, M.L., Hutt, K.R., Liang, T.Y., Pasquinelli, A.E., Yeo, G.W., Comprehensive discovery of endogenous Argonaute binding sites in Caenorhabditis elegans. Nat. Struct. Mol. Biol. 17 (2010), 173–179.